According to a new report, published by KBV research, The Global Surgical Dressing Market size is expected to reach $6.9 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,628.1 million units experiencing a growth of 4.9% (2019-2022).
The Hospitals segment is registering a CAGR of 4.6 % during the forecast period. Due to the rise in number of surgeries around the globe after the pandemic. There has been a corresponding increase in the demand for surgical dressings in hospitals worldwide to cover and protect surgical incisions and other types of wounds, prevent infection, and promote healing with the number of surgeries and medical procedures. In addition, advanced wound care products, including dressings incorporating antimicrobial agents and other innovative technologies, have further driven the demand for surgical dressings in hospitals.
The Primary Dressing segment led the Global Surgical Dressing Market by Product in 2022; thereby, achieving a market value of $3.0 billion by 2030, growing at a CAGR of 4.5 % during the forecast period. Surgical wounds often produce exudate, which is a mixture of blood, serum, and other fluids. Primary dressings can absorb and manage this exudate, preventing it from pooling in the wound area, which can help reduce the risk of infection and promote healing. Primary dressings are typically non-adherent and are designed to minimize trauma to the wound during dressing changes. This reduces pain and discomfort for the patient and helps prevent disruption to the healing tissue.
The Diabetes Based surgeries segment is growing at a CAGR of 4.2 % during the forecast period. The rising prevalence of diabetes and diabetic foot ulcers is a significant factor propelling the segment's expansion. Surgical wound dressing products that promote rapid healing, such as hydrogels or silver and collagen dressings, are commonly used to treat diabetic foot ulcers. With an increase in the number of diabetic patients and the prevalence of diabetic foot ulcers, the segment is expected to grow during the forecast period.
The North America region dominated the Global Surgical Dressing Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.3 billion by 2030. The Europe region is anticipated to grow at a CAGR of 4.7% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 5.8% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/surgical-dressing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of 3M Company, Smith & Nephew PLC, Molnlycke Health Care AB, Convatec, Inc., Johnson & Johnson, Baxter International, Inc., Coloplast Group, Medtronic PLC, Integra LifeSciences Holdings Corporation and Cardinal Health, Inc.
By End-use(Volume, Million Units, USD Billion/Million, 2019 - 2030)
By Product (Volume, Million Units, USD Billion/Million, 2019 - 2030)
By Application (Volume, Million Units, USD Billion/Million, 2019 - 2030)
By Geography (Volume, Million Units, USD Billion/Million, 2019 - 2030)
Companies Profiled
Unique Offerings 
